Free consultation for products developed in China
Do you have product developed in China? Are you planning to submit clinical trial in UK but you don’t know what is required? Please contact us and we are happy…
Continue readingRegulatory
Bitesize Regulatory News 25 Apr 2022
International The International Council for Harmonization (ICH) are preparing new guidelines for analytical methods used by manufacturers for testing medicines post approval. According to the feedback from ICH the purpose…
Continue readingBitesize Regulatory News 25 Jan 2022
Europe EMA has released a new initiative called ‘Accelerating Clinical Trials in the EU (ACT EU)’. According to the paper it will adapt some of the methods used in COVID…
Continue readingBitesize Regulatory News 23 Nov 2021
USA A study looking into RWD from 50 post-approval confirmatory studies requested by FDA shows that data is inconclusive and difficult to analyse. The authors mentioned that some of the…
Continue readingBitesize Regulatory News 5 Oct 2021
USA FDA has issued a new draft guideline for safety reporting which is expected to be finalised in Nov 2021. In the new edition they acknowledge that clinical trials are…
Continue readingFDA Legislation Changes: July 2018 FDA Extends Access to Experimental Drugs
FDA extended access program started back in 2009 and it allowed patients with life-threatening diseases who have exhausted all other options to try experimental drugs, which are not on the…
Continue readingWhat Are the Criteria for Enrolling People with Intellectual Disabilities in Clinical Research?
It is generally accepted that people with intellectual disabilities are not considered in clinical research if the type of the disease could be studied with people without disabilities. The reasons…
Continue readingWhat to Expect from the Changes in EU Clinical Trials Regulations?
If you are working with hospitals based in Europe or you are team member of a clinical trials team in a European hospital you are probably already aware of the…
Continue readingWhen Do You Need IND Application?
In October 2015 FDA released a clarification regarding IND application requirements. Their clarification is regarding queries and confusions amongst sponsors, investigators and RECs when do they need to apply for…
Continue readingChanges in European GCP Guidelines and How They Will Affect the Hospitals?
European Medicine Agency has started reviewing the GCP guide with the idea to adopt it to the changes in the modern world, including new technologies, changes in business models, new…
Continue reading
Page 1 of 2
Next